Skip to content
DraconiticResearch
Search Sources API
216,686 studies31 sourcesUpdated 13 min ago

Oncology

5,539 studies453 in 7 days2,591 in 30 days

Filters
Type
Date
Clear

Latest

5,539 studies

  1. Risk-Window Palbociclib Exposure Delays ErbB2-Driven Mammary Tumorigenesis and Suppresses Mammary Epithelial Cell Stemness
    Y. Liu, A. B. Parris, Z. Ma +3
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  2. Comparative Genomic and Epigenetic Landscape of Histone H3.3 G34R and K27M-Mutated Pediatric High-Grade Glioma Suggests Divergent Precision Oncology Strategies
    Z. Islam, L. Zhou, W. S. El-Deiry
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  3. Metabolic Targeting of SREBP1 Reprograms the Obesity-Driven Ascites Immune Microenvironment and Enhances Chemotherapy Response in Obesity-Associated Ovarian Cancer
    J. Yang, T. S. HILLIARD, Y. LIU +12
    bioRxivPreprintCC BYFull textOncologybioRxiv
  4. Targeting Tumor Immunity: Statins as a Repurposed Strategy for Preventing Ovarian Cancer Advancement
    J. M. Liberto, S. Qi, M. M. Rana +2
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. Dynamics of circulating tumor cell subsets defined by PSMA and EpCAM predict survival in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617
    M. J. Lee, L. Yu, N. Zorko +5
    bioRxivPreprintCC BYFull textOncologybioRxiv
  6. Structural and mechanistic insights into OCTN1-mediated transport and cancer cell proliferation.
    Binghong Xu, Shengjian Liang, Ziyu Wang +10
    Nature communicationsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  7. Type 2 Deiodinase in Cancer-Associated Fibroblasts: A Potential Therapeutic Target in Many Types of Cancer
    M. G. Carroll, N. Mukhtar, J. Calhoun +29
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  8. Incremental Predictive Value and Representation of Transcriptomic Features for Immunotherapy Response in Advanced Urothelial Carcinoma
    G. Y. Han, H. Tai, F. Wang
    medRxivPreprintCC BYFull textOncologymedRxiv
  9. Distinct Anaerobic Microbial Signature Differentiates Anal Squamous Cell Carcinoma From High-Grade Squamous Intraepithelial Lesions: A Prospective Metagenomic Study
    B. Nolasco, T. Lambert, K. Luo +8
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  10. Beyond tumor volume: connectomic measures of tumor burden provide superior prognostic information across tumor compartments in glioblastoma
    J. Falco-Roget, A. Ielo, A. Janus +11
    medRxivPreprintCC BY-NCFull textOncologymedRxiv
  11. Chemotherapy and neuroprotection: one carbazole compound, two functions
    Lauriane Bosc, David Balayssac, Chantal Thibert +2
    Médecine/SciencesPeer-reviewedCC BY 4.0Full textOncologyPharmacology & toxicologyHAL
  12. Is endobronchial ultrasound-guided bronchoscopy (EBUS) transbronchial needle aspiration (TBNA) enough for the diagnosis of mediastinal lymphadenopathy? A cohort analysis
    Kimberly Taha, Patrice Roll, Julie Tronchetti +2
    Respiratory Medicine and ResearchPeer-reviewedCC BY 4.0Full textOncologyHAL
  13. Prise en charge chirurgicale du cancer bronchique non à petites cellules opérable : vers de nouveaux paradigmes
    Mathilde Prieto, Antonio Bobbio, Ludovic Fournel +7
    Bulletin du CancerPeer-reviewedLicence not stated2 citedOncologyHAL
  14. Perspective: Do Fasting, Caloric Restriction, and Diets Increase Sensitivity to Radiotherapy? A Literature Review
    Philippe Icard, Luc Ollivier, Patricia Forgez +5
    Advances in NutritionPeer-reviewedLicence not stated25 citedMedical imaging & radiologyNutritionOncologyHAL
  15. Cross-species spatial profiling links progranulin to an immune suppressive niche in brain metastasis
    N. M. Eskow, K. Prutisto-Chang, M. A. Gomez-Munoz +17
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  16. Comprehensive Pan-Cancer Analysis Reveals the Prognostic, Molecular, and Immunological Significance of EPS8
    A. Juoairia, A. Akter, R. J. Nima +1
    bioRxivPreprintCC BYFull textOncologybioRxiv
  17. Physiological folate levels constrain nucleotide synthesis and increase dependence on nucleotide salvage
    R. Elbashir, K. L. Abbott, D. L. Ramesh +15
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  18. Cross-Source Progression Assessment in Advanced Pancreatic Cancer: An Opportunity-Adjusted Six-State Analysis
    H. A. Jaareh, F. Habash, S. Mustafa +1
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  19. Fatty acid synthase in cardiovascular disease: from molecular mechanisms to therapeutic targeting
    Dina Ibrahim, Mohamed S Zaghloul, Bera Koklu +4
    Cardiovascular ResearchPeer-reviewedPublisher termsFull textOncologyPMC
  20. Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma
    Berkay Yeşilyurt, Ismet Seven, Fahriye Tuğba Köş
    Future OncologyPeer-reviewedLicence not statedFull textOncologyPMC
  21. Spatially resolved multimodal hallmarks of response to neoadjuvant immunotherapies in the melanoma ecosystem in 2D and 3D
    Z. Liu, X. Song, W.-S. Chen +21
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  22. Telmisartan alters the transcriptomes of cancer associated fibroblasts and fibrocytes in a solid tumour model
    C.-M. Lee, N. Telkar, B. J. Wadsworth +9
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  23. Merlin restoration prevents schwannoma progression in a genetically engineered mouse model of NF2-SWN
    J. Vitte, C. Chiasson-MacKenzie, B. K. Cole +2
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  24. From DNA damage to systemic immunity: Interaction networks in radio-immunotherapy.
    Ruixue Huang
    Cell insightPeer-reviewedCC BYFull textOncologyEurope PMC
  25. An AI Model Identifies Chemotherapy Benefit in Node-Negative HR+/HER2- Breast Cancer Patients from TAILORx, a Phase 3 Randomized Clinical Trial
    N. Chan, C. Tang, D. Biswas +14
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv